NEWS
Our Latest News
ARCHIMED Successfully Completes Take-private of Esperion Therapeutics
Esperion Therapeutics is a commercial-stage biopharmaceutical company bringing innovative cardiometabolic and rare/orphan disease therapies to market for patients with unmet medical needs.
ARCHIMED Life Science Tools & Services acquires IRAB, a leading independent radiopharmaceuticals platform
June
9,
2026
ARCHIMED Healthcare IT sells global digital health solutions provider Ametris to Signant Health
May
28,
2026
368